Clinical Trial Update: Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating letrozole for breast cancer prevention in postmenopausal women at increased risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Post-Menopausal, Breast Cancer | Phase 2 | Status: UNKNOWN